LGR5 expression was more frequently observed in BC with higher T stages (P < 0.001), whereas there were no correlations with lymphovascular invasion (P = 0.428), N stages (P = 0.748), or AJCC (7th edition) tumor stages (P = 0.545). Here, LGR5 is linked to breast cancer.